Latest News

First patient randomised in trial of phosphate transporter inhibitor in treatment...

R1 Therapeutics has announced that the first patient has been randomised in its global phase 2b trial of AP306, a first-in-class pan phosphate transporter...

Features

Advancing AV fistula training: From first stitch to functional flow

Balazs Gasz, consultant cardiac surgeon at Zala County Hospital (Zalaegerszeg, Hungary) reports on the Surgical Arteriovenous (AV) Anastomosis Workshop taking place at the 2025...

‘Lively’ debate anticipated during CX Vascular Access and Renal Interventions session

A dedicated all-day session at CX 2025 (Wednesday 23 April, Auditorium 3) will address critical challenges in vascular access and renal interventions, featuring multiple...

Videos

In the second installment of our two-part focus on the re-emergence of endoAVF systems during CX 2026, host Nick Inston (University Hospital Birmingham NHS Foundation Trust, Birmingham, UK) and guests Alexandros Mallios (Hôpital Paris Saint-Joseph, Paris, France), Kate Steiner...

Most read

Features

Profiles

Monnie Wasse

Bart Dolmatch

Debbie Brouwer-Maier